Reaction
Cystic Fibrosis Hepatic Disease reporting signals
As of the last recalculation, Cystic Fibrosis Hepatic Disease appears in 23 FAERS reports alongside 4 co-occurring drug terms. The strongest observed disproportionality signal is DORNASE ALFA (PRR 972.2).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Dornase Alfa | 11 | 972.2 | 972.7 |
| Elexacaftor, Tezacaftor, And Ivacaftor | 7 | 729.7 | 730.1 |
| Ivacaftor | 4 | 551.4 | 551.7 |
| Lumacaftor And Ivacaftor | 3 | 364.2 | 364.3 |